Atrial fibrillation: maintenance of sinus rhythm versus rate control

The American Journal of Cardiology
S M Sopher, A J Camm

Abstract

Atrial fibrillation represents a common and challenging arrhythmia. A rational approach to management of the individual case depends on careful assessment of the temporal of the arrhythmia, any associated cardiovascular disease, and any particular features suggesting the advisability or risks of any particular treatment regimen. The nature of an arrhythmia and of individual patient factors change over time, requiring a flexible approach to long-term treatment that may be defined only after months or years. While new treatment options such as catheter ablation techniques and implantable atrial defibrillators are being tested, old therapies (e.g., low-dose amiodarone) are undergoing reappraisal. Increasing recognition of the dangers of antiarrhythmic therapy used to maintain sinus rhythm is focusing attention on nonpharmacologic methods. All patients with persistent atrial fibrillation merit serious consideration for direct current cardioversion before accepting that atrial fibrillation is permanent, and many patients may benefit from more than one attempt to restore and maintain sinus rhythm.

References

Mar 1, 1992·Annals of Internal Medicine·A RothS Laniado
Apr 1, 1992·The Annals of Thoracic Surgery·J J DefauwJ M de Bakker
Jul 15, 1992·Annals of Internal Medicine·R H Falk
Feb 15, 1992·The American Journal of Cardiology·M HaissaguerreJ F Warin
May 1, 1991·The American Journal of Cardiology·E L Pritchett, W E Wilkinson
Feb 1, 1991·The American Journal of Cardiology·B Strasberg
Mar 15, 1991·Journal of the American College of Cardiology·J W LeitchG Guiraudon
Apr 1, 1991·Annals of Internal Medicine·R H Falk, J I Leavitt
Nov 1, 1990·Journal of the American College of Cardiology·L ToivonenF Morady
Dec 1, 1990·American Heart Journal·N D MostowL Rakita
May 15, 1990·The American Journal of Cardiology·C P LauC H Cheng
Jul 1, 1990·Journal of the American College of Cardiology·T Lundström, L Rydén
Mar 1, 1988·Journal of the American College of Cardiology·F H WittkampfF L Meijler
Nov 1, 1988·Pacing and Clinical Electrophysiology : PACE·P AttuelP Coumel
Aug 10, 1989·The New England Journal of Medicine·J N Ruskin
Apr 1, 1989·The American Journal of Cardiology·S J Connolly, D L Hoffert
May 14, 1988·British Medical Journal·M J MetcalfeN Paterson
Aug 25, 1988·The American Journal of Cardiology·K J Hellestrand
Feb 11, 1988·The New England Journal of Medicine·T W Smith

❮ Previous
Next ❯

Citations

Apr 11, 2003·Pacing and Clinical Electrophysiology : PACE·H HsiuW K Wang
Jun 4, 1999·Journal of Cardiovascular Electrophysiology·I C Van GelderH J Crijns
Apr 7, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·L ObergasselC Stellbrink
Aug 17, 2004·Basic Research in Cardiology·Kiriakos KirmanoglouAlfons E Schäfler
Apr 26, 2003·International Journal of Cardiology·Carlo Pappone, Salvatore Rosanio
Aug 10, 2002·Current Cardiology Reports·Gerald V NaccarelliJerry Luck
Jul 1, 1997·Clinical Cardiology·L L Mackstaller, J S Alpert
Jul 25, 2000·Pharmacotherapy·T L Lenz, D E Hilleman
Jan 26, 2005·Zeitschrift für Kardiologie·J R Ehrlich, S H Hohnloser
May 3, 2001·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·S H Hohnloser
Feb 25, 1998·Pacing and Clinical Electrophysiology : PACE·M DuytschaeverL Jordaens
Dec 17, 2011·International Journal of Clinical Practice·J A HodgkinsonF D R Hobbs
Jul 5, 2012·Pacing and Clinical Electrophysiology : PACE·Elisabetta TosoFiorenzo Gaita
Feb 22, 2003·American Heart Journal·Sally Birger BotkinBrian Olshansky
Jul 28, 1999·The Journal of the American Dental Association·B C Muzyka
Apr 19, 2015·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Chin-Yu LinShih-Ann Chen
Jun 27, 2006·The Annals of Thoracic Surgery·Marjan JahangiriJohn Camm
Feb 25, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·S H HohnloserG Grönefeld
May 15, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Gerian Grönefeld, Stefan H Hohnloser
Sep 16, 2006·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Isabelle C Van Gelder, Martin E W Hemels
Mar 8, 2000·The American Journal of Nursing·R S Bubien
Feb 28, 2001·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·M BrignoleR Sutton
Feb 28, 2001·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·J M McComb, G M Gribbin
Mar 19, 1999·Medizinische Klinik·P Weismüller, H J Trappe
Apr 25, 2003·Canadian Journal of Physiology and Pharmacology·Mohamed ChahineDaya R Varma
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·Y G Li, S H Hohnloser
Mar 3, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Martin E W HemelsIsabelle C Van Gelder
Oct 11, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Saga ItäinenJuhani K E Airaksinen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.